Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Springdale. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Springdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This is a Phase II randomized, double-blind, placebo controlled, multi-site study of Candin. It is designed to show the efficacy and safety of a 7-dose regimen of Candin over a two-year period in terms of reducing cancer recurrence rate by comparing the recurrence rates between the Candin and the placebo arm. The ratio of the number of subjects who will receive Candin versus placebo will be 3:1. Up to 100 subjects will be screened until 80 subjects are eligible for injection.
Sponsor: University of Arkansas
Check if you qualify for this head and neck cancer clinical trial in Springdale, AR
If you're searching for head and neck cancer treatment options in Springdale, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.